Resultados da busca - Markus Peck‐Radosavljevic

Refinar Resultados
  1. 1
    Review article: coagulation disorders in chronic liver disease

    Review article: coagulation disorders in chronic liver disease por Markus Peck‐Radosavljevic

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Drug Therapy for Advanced-Stage Liver Cancer

    Drug Therapy for Advanced-Stage Liver Cancer por Markus Peck‐Radosavljevic

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  3. 3
    Thrombocytopenia in Liver Disease

    Thrombocytopenia in Liver Disease por Markus Peck‐Radosavljevic

    Publicado em 1999
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  4. 4
    Thrombocytopenia in chronic liver disease

    Thrombocytopenia in chronic liver disease por Markus Peck‐Radosavljevic

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    Review article: systemic treatment of hepatocellular carcinoma

    Review article: systemic treatment of hepatocellular carcinoma por Matthias Pinter, Markus Peck‐Radosavljevic

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    Transarterial chemoembolization: Modalities, indication, and patient selection

    Transarterial chemoembolization: Modalities, indication, and patient selection por Wolfgang Sieghart, Florian Hucke, Markus Peck‐Radosavljevic

    Publicado em 2015
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  7. 7
    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

    Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups por Matthias Pinter, Bernhard Scheiner, Markus Peck‐Radosavljevic

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  8. 8
    Oocytes from the Mutant Restricted Ovulator Hen Lack Receptor for Very Low Density Lipoprotein

    Oocytes from the Mutant Restricted Ovulator Hen Lack Receptor for Very Low Density Lipoprotein por Johannes Nimpf, Markus Peck‐Radosavljevic, Wolfgang J. Schneider

    Publicado em 1989
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Cancer and liver cirrhosis: implications on prognosis and management

    Cancer and liver cirrhosis: implications on prognosis and management por Matthias Pinter, Michael Trauner, Markus Peck‐Radosavljevic, Wolfgang Sieghart

    Publicado em 2016
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    The burden of liver disease in Europe: A review of available epidemiological data

    The burden of liver disease in Europe: A review of available epidemiological data por Martin Blachier, Henri Leleu, Markus Peck‐Radosavljevic, Dominique Valla, Françoise Roudot‐Thoraval

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  11. 11
    Systemic Therapy of Advanced Hepatocellular Carcinoma

    Systemic Therapy of Advanced Hepatocellular Carcinoma por Peter R. Galle, Jean‐François Dufour, Markus Peck‐Radosavljevic, Jörg Trojan, Arndt Vogel

    Publicado em 2020
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  12. 12
    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study

    The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma – a pilot study por Matthias Pinter, Wolfgang Sieghart, Thomas Reiberger, Nataliya Rohr‐Udilova, Arnulf Ferlitsch, Markus Peck‐Radosavljevic

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents

    Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE-covered stentgrafts versus bare stents por Bernhard Angermayr, Manfred Cejna, Franz Koenig, F. Karnel, Franz Hackl, Alfred Gangl, Markus Peck‐Radosavljevic

    Publicado em 2003
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C

    Von Willebrand Factor as a new marker for non‐invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C por A Maieron, Petra Salzl, Markus Peck‐Radosavljevic, Michael Trauner, S Hametner, R Schöfl, Péter Ferenci, Monika Ferlitsch

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    Meta‐analysis: <scp>ARFI</scp> elastography versus transient elastography for the evaluation of liver fibrosis

    Meta‐analysis: <scp>ARFI</scp> elastography versus transient elastography for the evaluation of liver fibrosis por Simona Bota, Harald Herkner, Ioan Sporea, Petra Salzl, Roxana Şirli, Adriana Maria Neghină, Markus Peck‐Radosavljevic

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  16. 16
    Five‐year on‐treatment efficacy of lamivudine‐, tenofovir‐ and tenofovir + emtricitabine‐based HAART in HBV–HIV‐coinfected patients

    Five‐year on‐treatment efficacy of lamivudine‐, tenofovir‐ and tenofovir + emtricitabine‐based HAART in HBV–HIV‐coinfected patients por Lana Kosi, Thomas Reiberger, B.A. Payer, Katharina Grabmeier‐Pfistershammer, Robert Straßl, Armin Rieger, Markus Peck‐Radosavljevic

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study

    Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study por Rémy Schwarzer, Danijel Kivaranovic, Rafael Paternostro, Mattias Mandorfer, Thomas Reiberger, Michael Trauner, Markus Peck‐Radosavljevic, Arnulf Ferlitsch

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    Rapid suppression of hematopoiesis by standard or pegylated interferon-α

    Rapid suppression of hematopoiesis by standard or pegylated interferon-α por Markus Peck‐Radosavljevic, Martina Wichlas, Monika Homoncik–Kraml, Anna Kreil, Harald Hofer, Wolfgang Jessner, Alfred Gangl, Peter Ferenci

    Publicado em 2002
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    IP-10 Correlates with Hepatitis C Viral Load, Hepatic Inflammation and Fibrosis and Predicts Hepatitis C Virus Relapse or Non-Response in HIV–HCV Coinfection

    IP-10 Correlates with Hepatitis C Viral Load, Hepatic Inflammation and Fibrosis and Predicts Hepatitis C Virus Relapse or Non-Response in HIV–HCV Coinfection por Thomas Reiberger, Judith H. Aberle, Michael Kundi, Norbert Kohrgruber, Armin Rieger, Alfred Gangl, Heidemarie Holzmann, Markus Peck‐Radosavljevic

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Personalized treatment of patients with very early hepatocellular carcinoma

    Personalized treatment of patients with very early hepatocellular carcinoma por Alessandro Vitale, Markus Peck‐Radosavljevic, Edoardo G. Giannini, Éric Vibert, Wolfgang Sieghart, Sven Van Poucke, Timothy M. Pawlik

    Publicado em 2016
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:

Ferramentas de busca: